• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Impact of the variations in potential glycosylation sites of the hemagglutinin of H9N2 influenza virus

tetano

Editor, Senior Moderator
Virus Genes. 2018 Dec 29. doi: 10.1007/s11262-018-1623-7. [Epub ahead of print]
[h=1]Impact of the variations in potential glycosylation sites of the hemagglutinin of H9N2 influenza virus.[/h] Peng Q[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Zhu R[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Wang X[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Shi H[SUP]4,[/SUP][SUP]5,[/SUP][SUP]6,[/SUP][SUP]7,[/SUP][SUP]8[/SUP], Bellefleur M[SUP]9[/SUP], Wang S[SUP]10[/SUP], Liu X[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Variations in the potential glycosylation sites were observed in hemagglutinin (HA) sequences of H9N2 avian influenza virus isolated in China, deposited in the Influenza Virus Resource of NCBI before 2017, which showed a deleted glycosylation site at amino acid residue 218, and an introduced glycosylation site at amino acid residue 313. Based on the variations in the glycosylation sites at these amino acids, H9N2 avian influenza viruses could be divided into three categories. Firstly, most of the H9N2 influenza viruses were 218G[SUP]+[/SUP] viruses; less 313G[SUP]+[/SUP] viruses were isolated between 1997 and 2004. Secondly, the occurrence of the 218G[SUP]+[/SUP]/313G[SUP]+[/SUP] viruses increased, while the 218G[SUP]+[/SUP]/313G[SUP]-[/SUP] viruses decreased from 2005 to 2012. Thirdly, from 2013 to 2016, the 218G[SUP]-[/SUP]/313G[SUP]+[/SUP] viruses were predominant compared to the 218G[SUP]+[/SUP]/313G[SUP]+[/SUP] viruses. Here, based on an F/98 virus backbone, a 218G[SUP]+[/SUP]/313G[SUP]-[/SUP] virus, two reassortment viruses were generated, and named rF/HA218G[SUP]+[/SUP]/313G[SUP]+[/SUP] and rF/HA 218G[SUP]+[/SUP]/313G[SUP]-[/SUP], respectively. HA protein migration demonstrated that the glycosylation sites at amino acid residues 313 and 218 were both functional. The absence of the glycosylation site at amino acid residue 218 and the presence of the glycosylation site at amino acid residue 313 increased antibody binding and moderately prevented the virus from escaping neutralization with homologous antisera. Additionally, compared to the F/98 virus (218G[SUP]+[/SUP]/313G[SUP]-[/SUP]), the viruses rF/HA218G[SUP]+[/SUP]/313G[SUP]+[/SUP] or rF/HA218G[SUP]-[/SUP]/313G[SUP]+[/SUP] showed significantly increased infectivity of MDCK cells, chicken embryo eggs, and trachea and lung tissue of SPF chickens, but did not display differences in airborne spread in chickens or infectivity of mice compared with its parental virus F/98.


[h=4]KEYWORDS:[/h] Aa residue 218; Aa residue 313; Glycosylation sites; H9N2; Hemagglutinin

PMID: 30594968 DOI: 10.1007/s11262-018-1623-7
 
Back
Top Bottom